ASCO 2016: Dr. O'Brien on Idelalisib and liver... - CLL Support

CLL Support

23,089 members39,652 posts

ASCO 2016: Dr. O'Brien on Idelalisib and liver inflammation

bkoffman profile image
bkoffmanCLL CURE Hero
2 Replies

This week in the Conference Coverage section of the CLL Society website, we’ve posted another interview with Dr. Susan O’Brien out of UCI where we discussed an ASCO 2016 abstract about liver inflammation associated with idelalisib in relapsed CLL patients. You can view that interview here. cllsociety.org/2016/09/asco...

We’re pleased to announce that we’ve posted a CLL Doctor List in our CLL Toolbox. This list is composed of CLL physicians recommended by our readers. We appreciate all who contributed to the list. Thank you! You can access it here. cllsociety.org/toolbox/cll-...

This is a strictly patient driven list so feel free to suggested additions.

We reference other helpful list too.

Stay strong.

We are all in this together.

Brian

cllsociety.org

bkoffman.blogspot.com

Written by
bkoffman profile image
bkoffman
CLL CURE Hero
To view profiles and participate in discussions please or .
Read more about...
2 Replies
AussieNeil profile image
AussieNeilPartnerAdministrator

Thanks Brian!

I've added the link to your list of CLL physicians recommended by your readers into our list of international CLL information resources:

healthunlocked.com/cllsuppo....

Members, if your doctor isn't on the list and you consider they should be, you can recommend them here:

cllsociety.org/contact-us

Neil

bkoffman profile image
bkoffmanCLL CURE Hero in reply to AussieNeil

Thanks. We have not vetted the doctors though most are well respected CLL specialists. It is all from our patient survey and we want to keep it fresh and accurate.

Not what you're looking for?

You may also like...

ASCO 2016: Dr. Susan O’Brien where she discusses frontline data on Acalabrutinib in CLL

We are 8 weeks out from the 2016 annual meeting of the American Society of Hematology and realize...

EHA 2016: Professor Hallek on the Unmet Needs in CLL

Today in the 2016 Conference Coverage section of the CLL Society website, we’ve posted an interview...

ASH 2015: Dr. John M Pagel on the Problems with Idelalisib as Frontline Therapy in CLL

It has been a while since I posted an interview on my blog first instead of the CLL Society...

Dr. Mato on what really happens when we must stop our ibrutinib or idelalisib

Friends, I hope my US-based readers had a happy healthy holiday weekend. This past weekend, in...

My Take on 3 Interesting Papers on CLL from ASCO 2015

Friends, This week on CLL Society (http://cllsociety.org) in our 2015 conference coverage...